1. Home
  2. CVGI vs LPTX Comparison

CVGI vs LPTX Comparison

Compare CVGI & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVGI
  • LPTX
  • Stock Information
  • Founded
  • CVGI 2000
  • LPTX 2011
  • Country
  • CVGI United States
  • LPTX United States
  • Employees
  • CVGI N/A
  • LPTX N/A
  • Industry
  • CVGI Auto Parts:O.E.M.
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CVGI Consumer Discretionary
  • LPTX Health Care
  • Exchange
  • CVGI Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • CVGI 34.0M
  • LPTX 119.6M
  • IPO Year
  • CVGI 2004
  • LPTX N/A
  • Fundamental
  • Price
  • CVGI $1.97
  • LPTX $0.30
  • Analyst Decision
  • CVGI Buy
  • LPTX Hold
  • Analyst Count
  • CVGI 1
  • LPTX 1
  • Target Price
  • CVGI $10.00
  • LPTX N/A
  • AVG Volume (30 Days)
  • CVGI 578.0K
  • LPTX 3.2M
  • Earning Date
  • CVGI 08-04-2025
  • LPTX 08-11-2025
  • Dividend Yield
  • CVGI N/A
  • LPTX N/A
  • EPS Growth
  • CVGI N/A
  • LPTX N/A
  • EPS
  • CVGI N/A
  • LPTX N/A
  • Revenue
  • CVGI $698,524,000.00
  • LPTX N/A
  • Revenue This Year
  • CVGI N/A
  • LPTX N/A
  • Revenue Next Year
  • CVGI $7.37
  • LPTX N/A
  • P/E Ratio
  • CVGI N/A
  • LPTX N/A
  • Revenue Growth
  • CVGI N/A
  • LPTX N/A
  • 52 Week Low
  • CVGI $0.81
  • LPTX $0.22
  • 52 Week High
  • CVGI $5.69
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • CVGI 78.36
  • LPTX 37.54
  • Support Level
  • CVGI $1.25
  • LPTX $0.27
  • Resistance Level
  • CVGI $1.41
  • LPTX $0.32
  • Average True Range (ATR)
  • CVGI 0.13
  • LPTX 0.04
  • MACD
  • CVGI 0.07
  • LPTX -0.01
  • Stochastic Oscillator
  • CVGI 95.57
  • LPTX 16.48

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

Share on Social Networks: